Previous close | 38.40 |
Open | 38.40 |
Bid | 38.40 x N/A |
Ask | 39.00 x N/A |
Day's range | 38.40 - 38.60 |
52-week range | 27.00 - 40.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 15 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
COSTA MESA, Calif., May 07, 2024--Healthcare providers and patients are in rare agreement that healthcare access and service-levels are improving, according to the Experian Health 2024 State of Patient Access survey. Almost a third (28%) of patients and 55 percent of providers surveyed say the environment is getting better while patients still say the top challenge is seeing a practitioner quickly.
Stephen Wright looks at a UK stock that's outperformed the broader market since its IPO in 2006 and looks set to keep doing so with the emergence of AI. The post This FTSE 100 stock has what it takes to keep beating the market appeared first on The Motley Fool UK.
Many investors overlook FTSE 100 companies when seeking exposure to the artificial intelligence sector, but these British AI stocks are worth considering. The post 2 FTSE 100 shares I’d buy for the artificial intelligence (AI) boom! appeared first on The Motley Fool UK.